Skip to content
PICO Portalanswers from OpenAlex

Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B

PaperCitations, authors & open-access status

Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B is a paper indexed in PICO Portal from OpenAlex.

How many citations does Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B have?

PICO Portalcitation count

Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B has 350 citations in the OpenAlex counts PICO Portal stores.

When was Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B published?

PICO Portalyear

Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B has 2023 year in the PICO Portal index.

What is the open-access status of Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B?

PICO Portaloa status

Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B has bronze oa status in the PICO Portal index.

What is the DOI of Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B?

PICO Portaldoi

The DOI for Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B is on the source record.

What is the PMID of Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B?

PICO Portalpmid

The PMID for Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B is on the source record.

What is the OpenAlex record for Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B?

PICO Portalopenalex

The OpenAlex for Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial